Literature DB >> 21993617

Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis.

M B D'hooghe1, P Haentjens, G Nagels, T D'Hooghe, J De Keyser.   

Abstract

Female gender and hormones have been associated with disease activity in multiple sclerosis (MS). We investigated age at menarche, use of oral contraceptives and pregnancy in relation to progression of disability in relapsing onset and progressive onset MS. We conducted a cross-sectional survey among individuals with MS, registered by the Flemish MS Society in Belgium. A time-to-event analysis and Cox proportional hazard regression were performed with time to Expanded Disability Status Score (EDSS) of 6 (requires a cane) as outcome measure. Hazard ratios for the time from onset and the time from birth were adjusted for age at onset and immunomodulatory treatment. Data on 973 women with definite MS were collected. In the relapsing onset group, women with at least two pregnancies had a reduced risk to reach EDSS 6 compared with nulliparous women. In the progressive onset group, later age at menarche was associated with a reduced risk to reach EDSS 6, whereas oral contraceptive use was associated with a higher risk of reaching EDSS 6. Our study corroborates the association of pregnancies with a reduced progression of disability in relapsing onset MS. In progressive onset MS, a slower progression was found in women with a later onset of menarche and a more rapid progression occurred when women reported the use of oral contraceptives.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993617     DOI: 10.1007/s00415-011-6267-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Brain development during childhood and adolescence: a longitudinal MRI study.

Authors:  J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport
Journal:  Nat Neurosci       Date:  1999-10       Impact factor: 24.884

2.  Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis.

Authors:  Per Holmqvist; Mats Hammar; Anne-Marie Landtblom; Jan Brynhildsen
Journal:  Fertil Steril       Date:  2010-12       Impact factor: 7.329

Review 3.  Protecting axons in multiple sclerosis.

Authors:  A Wilkins; N Scolding
Journal:  Mult Scler       Date:  2008-07-16       Impact factor: 6.312

4.  Symptoms of multiple sclerosis in women in relation to sex steroid exposure.

Authors:  Per Holmqvist; Malin Wallberg; Mats Hammar; A-M Landtblom; Jan Brynhildsen
Journal:  Maturitas       Date:  2005-11-15       Impact factor: 4.342

5.  Prevalence of multiple sclerosis in Denmark 1950--2005.

Authors:  Joan Bentzen; Esben Meulengracht Flachs; Egon Stenager; Henrik Brønnum-Hansen; Nils Koch-Henriksen
Journal:  Mult Scler       Date:  2010-03-09       Impact factor: 6.312

6.  Costs and quality of life for patients with multiple sclerosis in Belgium.

Authors:  Gisela Kobelt
Journal:  Eur J Health Econ       Date:  2006-09

7.  Long-term effects of childbirth in MS.

Authors:  M B D'hooghe; G Nagels; B M J Uitdehaag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-11-25       Impact factor: 10.154

8.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

9.  Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients.

Authors:  E Roullet; M H Verdier-Taillefer; P Amarenco; G Gharbi; A Alperovitch; R Marteau
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

Review 10.  The role of puberty in the developing adolescent brain.

Authors:  Sarah-Jayne Blakemore; Stephanie Burnett; Ronald E Dahl
Journal:  Hum Brain Mapp       Date:  2010-06       Impact factor: 5.038

View more
  28 in total

Review 1.  The importance of studying sex differences in disease: The example of multiple sclerosis.

Authors:  Lisa C Golden; Rhonda Voskuhl
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 2.  An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis.

Authors:  Caila Vaughn; Aisha Bushra; Channa Kolb; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

Review 3.  Caring for Women with Multiple Sclerosis Across the Lifespan.

Authors:  Kelsey Rankin; Riley Bove
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

Review 4.  Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.

Authors:  Maria Pia Amato; Emilio Portaccio
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

Review 5.  Contraceptive use among women with multiple sclerosis: a systematic review.

Authors:  Lauren B Zapata; Titilope Oduyebo; Maura K Whiteman; Maria K Houtchens; Polly A Marchbanks; Kathryn M Curtis
Journal:  Contraception       Date:  2016-07-21       Impact factor: 3.375

Review 6.  Management of women with multiple sclerosis through pregnancy and after childbirth.

Authors:  Patricia K Coyle
Journal:  Ther Adv Neurol Disord       Date:  2016-03-02       Impact factor: 6.570

7.  Sex differences in resting-state functional connectivity in multiple sclerosis.

Authors:  K A Koenig; M J Lowe; J Lin; K E Sakaie; L Stone; R A Bermel; E B Beall; S M Rao; B D Trapp; M D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

Review 8.  Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding.

Authors:  Rhonda Voskuhl; Callene Momtazee
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 9.  Impact of sex hormones on immune function and multiple sclerosis development.

Authors:  María C Ysrraelit; Jorge Correale
Journal:  Immunology       Date:  2018-10-11       Impact factor: 7.397

10.  Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study.

Authors:  Adil Harroud; John A Morris; Vincenzo Forgetta; Ruth Mitchell; George Davey Smith; Stephen J Sawcer; J Brent Richards
Journal:  Neurology       Date:  2019-03-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.